Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

Research Network

Collaboration Network

7 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Mayo Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Craig Hofmeister, MD

Ohio State University

Moderately Similar
4 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score30%

Ajai Chari, MD

Icahn School of Medicine at Mount Sinai

Moderately Similar
5 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score30%

Sham Mailankody, MBBS

Memorial Sloan Kettering Cancer Center

Moderately Similar
5 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score30%

Steven D Reich, MD

Triphase Research and Development I Corp

Moderately Similar
5 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score30%

Charles Erlichman

Mayo Clinic

Moderately Similar
6 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score30%

Ryotaro Nakamura

City of Hope Medical Center

Moderately Similar
10 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Shaji Kumar, M.D.

Mayo Clinic

Moderately Similar
7 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score30%

Robert Orlowski

M.D. Anderson Cancer Center

Moderately Similar
4 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Amrita Krishnan

City of Hope Medical Center

Moderately Similar
4 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Hongyu Zhang, MD/PhD

Peking University Shenzhen Hospital, China

Moderately Similar
3 trials

Shared therapeutic areas:

Refractory Multiple Myeloma
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01212952Phase 1/2StudyChair

Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma
Completed

All 1 trials loaded